real-time news and commentary for investors
Thursday, Oct 10
Celldex Therapeutics on the move
- Celldex Therapeutics (CLDX +10.3%) rallies on heavy volume as it takes back some ground lost over the last week.
- The healthcare stock has been in focus with results for the company's glioblastoma multiform drug, CDX-110, scheduled to be released soon.
- SA contributor Brian Nichols notes there is reason to believe the data will come in positive.